References
- Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000; 407:923 - 926
- Gettins PG. Serpin structure, mechanism and function. Chem Rev 2002; 102:4751 - 4804
- Huntington JA. Shape-shifting serpins—advantages of a mobile mechanism. Trends Biochem Sci 2006; 31:427 - 435
- Im H, Ahn HY, Yu MH. Bypassing the kinetic trap of serpin protein folding by loop extension. Protein Sci 2000; 9:1497 - 1502
- Anfinsen CB. Principles that govern the folding of protein chains. Science 1973; 181:223 - 230
- Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z alpha1-antitrypsin accumulation in the liver. Nature 1992; 357:605 - 607
- Gooptu B, Lomas DA. Polymers and inflammation: disease mechanisms of the serpinopathies. J Exp Med 2008; 205:1529 - 1534
- Perlmutter DH, Brodsky JL, Balistreri WF, Trapnell BC. Molecular pathogenesis of alpha-1-antitrypsin deficiency-associated liver disease: a meeting review. Hepatology 2007; 45:1313 - 1323
- Davies MJ, Lomas DA. The molecular aetiology of the serpinopathies. Int J Biochem Cell Biol 2008; 40:1273 - 1286
- Yamasaki M, Li W, Johnson DJ, Huntington JA. Crystal structure of a stable dimer reveals the molecular basis of serpin polymerization. Nature 2008; 455:1255 - 1258
- Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J. Prediction of amyloid fibril-forming proteins. J Biol Chem 2001; 276:12945 - 12950
- Carrell RW, Lomas DA. Conformational disease. Lancet 1997; 350:134 - 138
- Lomas DA, Carrell RW. Serpinopathies and the conformational dementias. Nat Rev Genet 2002; 3:759 - 768
- Bennett MJ, Sawaya MR, Eisenberg D. Deposition diseases and 3D domain swapping. Structure 2006; 14:811 - 824
- Liu Y, Eisenberg D. 3D domain swapping: as domains continue to swap. Protein Sci 2002; 11:1285 - 1299
- Ferreira ST, Vieira MN, De Felice FG. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 2007; 59:332 - 345
- Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 2003; 81:678 - 699
- Fairbanks KD, Tavill AS. Liver disease in alpha1-antitrypsin deficiency: a review. Am J Gastroenterol 2008; 103:2136 - 2141
- Perlmutter DH. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 2006; 60:233 - 238
- Schmidt BZ, Perlmutter DH. Grp78, Grp94 and Grp170 interact with alpha1-antitrypsin mutants that are retained in the endoplasmic reticulum. Am J Physiol Gastrointest Liver Physiol 2005; 289:444 - 455
- Perlmutter DH. Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency. Cell Death Differ 2009; 16:39 - 45
- Galliciotti G, Sonderegger P. Neuroserpin. Front Biosci 2006; 11:33 - 45
- Miranda E, Lomas DA. Neuroserpin: a serpin to think about. Cell Mol Life Sci 2006; 63:709 - 722
- Kim D, Yu MH. Folding pathway of human alpha1-antitrypsin: characterization of an intermediate that is active but prone to aggregation. Biochem Biophys Res Commun 1996; 226:378 - 384
- Devlin GL, Chow MK, Howlett GJ, Bottomley SP. Acid Denaturation of alpha(1)-Antitrypsin: Characterization of a Novel Mechanism of Serpin Polymerization. J Mol Biol 2002; 324:859 - 870
- Tew DJ, Bottomley SP. Probing the equilibrium denaturation of the serpin alpha(1)-antitrypsin with single tryptophan mutants; evidence for structure in the urea unfolded state. J Mol Biol 2001; 313:1161 - 1169